legislation: 116-hr-8399
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116-hr-8399 | 116 | hr | 8399 | End Taxpayer Subsidies for Drug Ads Act | Taxation | 2020-09-25 | 2020-09-25 | Referred to the House Committee on Ways and Means. | House | Rep. Finkenauer, Abby [D-IA-1] | IA | D | F000467 | 2 | End Taxpayer Subsidies for Drug Ads Act This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public. | 2023-01-11T13:44:53Z | https://www.congress.gov/bill/116th-congress/house-bill/8399 |